Epidemiology and Clinical Characteristics of Non-Hodgkin Lymphoma in Mexico

被引:8
|
作者
Hernandez-Ruiz, Eleazar [1 ,2 ,5 ]
Alvarado-Ibarra, Martha [2 ]
Juan Lien-Chang, Lourdes Esthela [3 ]
Banda-Garcia, Luisa [4 ]
Luis Aquino-Salgado, Jorge [1 ]
Barragan-Ibanez, Gabriel [1 ]
Fabiola Ramirez-Romero, Eva [5 ]
Nolasco-Cancino, Cesar [6 ,7 ]
Herrera-Olivares, Wilfrido [8 ]
de Jesus Morales-Adrian, Javier [9 ]
Patricia Paredes-Lozano, Eugenia [10 ]
Eugenia Espitia-Rios, Maria [2 ]
Gonzalez Lopez-Elizalde, Maria de Monserrat [11 ]
Luis Lopez-Arroyo, Jose [12 ]
Enrique Trejo-Gomora, Jorge [13 ]
Antonio De la Pena-Celaya, Jose [2 ]
Luis Alvarez-Vera, Jose [2 ]
Luz Arana-Luna, Luara [2 ]
Martinez-Rios, Annel [14 ]
Resendiz-Olea, Rodrigo [14 ]
Jazmin Rodriguez-Velasquez, Lucero [1 ]
Zapata-Canto, Nidia [15 ]
Manuel Perez-Zuniga, Juan [2 ,14 ]
机构
[1] Hosp Reg Alta Especialidad Oaxaca, Serv Hematol, Oaxaca, Oaxaca, Mexico
[2] ISSSTE, Ctr Med Nacl 20 Noviembre, Serv Hematol, Mexico City, DF, Mexico
[3] Unidad Oncol & Serv Salud Estado Puebla, Serv Hematol, Puebla, Mexico
[4] Hosp Gen Zona 11 Xalapa, Serv Hematol, Xalapa, Veracruz, Mexico
[5] ISSSTE, Hosp Reg Presidente Juarez Oaxaca, Serv Hematol, Oaxaca, Oaxaca, Mexico
[6] Hosp Reg Doctor Juan Graham Casasus Villahermosa, Serv Hematol, Villahermosa, Tabasco, Mexico
[7] Hosp CERACOM, Serv Hematol, Villahermosa, Tabasco, Mexico
[8] ISSSTE, Serv Hematol, Hosp Reg Puebla, Puebla, Mexico
[9] ISSSTE, Serv Hematol, Hosp Reg Merida, Yucatan, Mexico
[10] Hosp Reg 1 Octubre ISSSTE, Serv Hematol, Mexico City, DF, Mexico
[11] Hosp H Queretaro, Serv Hematol, Queretaro, Mexico
[12] Hosp Gen B Ciudad Juarez, Serv Hematol, Cd Juarez, Chihuahua, Mexico
[13] Hosp San Angel Inn Univ, Serv Hematol, Mexico City, DF, Mexico
[14] Hosp Reg Ignacio Zaragoza ISSSTE, Serv Hematol, Mexico City, DF, Mexico
[15] Inst Nacl Cancerol, Mexico City, DF, Mexico
关键词
Non-Hodgkin lymphoma; Histological subtype; B-cell lymphomas; NK/T-cell lymphoma; Chemotherapy regimen; B-CELL LYMPHOMA; CLASSIFICATION; PATHOGENESIS; SURVIVAL;
D O I
10.14740/wjon1351
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: There is no epidemiological registry in Mexico. The information about the epidemiology in our country is obtained by these types of studies, such as multicentric studies. A lot of improvements in the survival in non-Hodgkin lymphoma patients had occurred in the last 20 years. The access to treatment in these types of pathology could change the prognostic factors in Mexican Mestizos patients. The primary objective of the study was to learn what the most frequent histological varieties of non-Hodgkin lymphoma in Mexico are. The secondary objectives included clinical characteristics, treatments used, treatment response, disease-free survival and overall survival. Methods: A retrospective, descriptive study of consecutive cases was carried out in 14 hospitals across 14 Mexican states with patients diagnosed with non-Hodgkin lymphoma using the World Health Organization (WHO) 2008 criteria. Inclusion criteria included: >= 18 years of age, male or female, any clinical stage at diagnosis, who had received any chemotherapy regimen, with a known outcome. Descriptive statistics was performed for all variables, and survival was assessed using Kaplan-Meier curves. Results: Totally, 609 patients were enrolled, of which 545 were B-cell lymphomas and 64 were T-cell lymphomas. Median ages were 61 and 50, respectively. B-cell lymphomas were more common in males with 52.1%, and 65.5% of T-cell lymphomas occurred in females. For B-cell lymphomas, the two most frequent histological subtypes were diffuse large B-cell lymphoma in 63.9%, followed by follicular lymphoma at 18%. Meanwhile, 50% of T-cell lymphomas were of the T/natural killer (NK) subtype, and 87.1% of the patients received a CHOP-like regimen. Radiotherapy was given to 31% of B-cell Lymphomas and 46.9% of T-cell lymphomas. Overall survival at 9 years was 84.6% for B-cell lymphomas, and 73.4% for T-cell lymphomas. Conclusions: Diffuse large B-cell lymphoma constitutes the most frequent subtype for B-cell lymphomas in Mexico. The most frequent T-cell lymphoma is the NK/T histological subtype.
引用
收藏
页码:28 / 33
页数:6
相关论文
共 50 条
  • [21] Modeling the Epidemiology of Indolent Non-Hodgkin Lymphoma (iNHL) in France
    Troussard, Xavier
    Herrera, Alain
    Cornet, Edouard
    Solal-Celigny, Philippe
    BLOOD, 2014, 124 (21)
  • [22] New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy
    Chihara, Dai
    Nastoupil, Loretta J.
    Williams, Jessica N.
    Lee, Paul
    Koff, Jean L.
    Flowers, Christopher R.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (05) : 531 - 544
  • [23] Epidemiology of non-Hodgkin's lymphoma in Occidental Canary Islands
    Llanos, M
    Oramas, J
    Aleman, R
    Batista, N
    Morales, M
    Dorta, J
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1206 - 1206
  • [24] The role of dietary factors in the epidemiology of non-Hodgkin's lymphoma
    Cross, Amanda J.
    Lim, Unhee
    LEUKEMIA & LYMPHOMA, 2006, 47 (12) : 2477 - 2487
  • [25] Non-Hodgkin lymphoma
    Armitage, James O.
    Gascoyne, Randy D.
    Lunning, Matthew A.
    Cavalli, Franco
    LANCET, 2017, 390 (10091): : 298 - 310
  • [26] EPIDEMIOLOGY OF THE NON-HODGKIN LYMPHOMA COLOMBIA 2000-2011
    Romero Martin, R. M.
    Chavez Diana, C. D.
    VALUE IN HEALTH, 2012, 15 (04) : A211 - A211
  • [27] EPIDEMIOLOGY OF NON-HODGKIN LYMPHOMA IN CONNECTICUT - 1935-1988
    ZHENG, TZ
    MAYNE, ST
    BOYLE, P
    HOLFORD, TR
    LIU, WL
    FLANNERY, J
    CANCER, 1992, 70 (04) : 840 - 849
  • [28] Non-Hodgkin lymphoma
    Shankland, Kate R.
    Armitage, James O.
    Hancock, Barry W.
    LANCET, 2012, 380 (9844): : 848 - 857
  • [29] Clinical Characteristics and Treatment Outcome of Pediatric Non-Hodgkin Lymphoma in East Asia
    Seo, J. J.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S211 - S211
  • [30] Effect of age on the characteristics and clinical behavior of non-Hodgkin's lymphoma patients
    Chan, WC
    Armitage, JO
    Gascoyne, R
    Connors, J
    Close, P
    Jacobs, P
    Norton, A
    Lister, TA
    Pedrinis, E
    Cavalli, F
    Berger, F
    Coiffier, B
    Ho, F
    Liang, R
    Schauer, A
    Hiddemann, W
    Diebold, J
    MacLennan, KA
    MullerHermelink, HK
    Nathwani, BN
    Weisenburger, DD
    Anderson, JR
    Roy, P
    ANNALS OF ONCOLOGY, 1997, 8 (10) : 973 - 978